CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily practice through Educational approach). A European observational study to evaluate the impact of educational material on the compliance and persistence rates to adjuvant aromatase inhibitor (AI) medication for postmenopausal women with hormone sensitive early breast cancer.
18 Years +
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
No locations available
Standard therapy + educational material